질염 치료제 시장 규모, 점유율, 성장 분석 : 질환별, 제품별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)
Vaginitis Therapeutics Market Size, Share, and Growth Analysis, By Disease (Anti-fungal, Anti-bacterial), By Product (Over-the-counter (OTC), Prescription), By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드:1663144
리서치사:SkyQuest
발행일:2025년 02월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 질염 치료제 시장 규모는 2023년에 37억 달러로 평가되며, 2024년 39억 9,000만 달러에서 2032년에는 72억 7,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 7.8%로 성장할 전망입니다.
세계 질염 치료제 시장은 질 감염증의 유병률 증가에 따라 효과적인 치료에 대한 수요가 급증하고 있습니다. 주요 시장 동향은 항균제 및 프로바이오틱스에 대한 관심 증가와 함께 개인화된 저침습적 솔루션으로의 전환을 보여줍니다. 기술 발전은 혁신적인 제형과 진단 툴의 개발을 촉진하고 있습니다. 주요 기업은 연구에 적극적으로 투자하고 파트너십을 맺어 제품 라인업을 확장하고 있습니다. 북미와 유럽은 탄탄한 의료 인프라와 높은 인식으로 인해 현재 시장을 주도하고 있지만, 아시아태평양의 신흥 국가들은 의료 접근성 향상과 질 건강에 대한 인식이 높아지면서 큰 성장 기회를 제공합니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
사례 연구
규제 분석
질염 치료제 시장 규모 : 질환별 & CAGR(2025-2032)
시장 개요
항진균
항균
호르몬
질염 치료제 시장 규모 : 제품별 & CAGR(2025-2032)
시장 개요
일반의약품(OTC)
처방전
질염 치료제 시장 규모 : 유통 채널별 & CAGR(2025-2032)
시장 개요
병원 약국
소매 약국
기타
질염 치료제 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Pfizer Inc.(USA)
Johnson & Johnson(USA)
Novartis AG(Switzerland)
GlaxoSmithKline plc(UK)
Bayer AG(Germany)
Sanofi(France)
Merck & Co., Inc.(USA)
Eli Lilly and Company(USA)
AstraZeneca plc(UK/Sweden)
AbbVie Inc.(USA)
Gilead Sciences, Inc.(USA)
Roche Holding AG(Switzerland)
Bristol Myers Squibb(USA)
Teva Pharmaceutical Industries Ltd.(Israel)
Astellas Pharma Inc.(Japan)
Mylan N.V.(USA)
Daiichi Sankyo Co., Ltd.(Japan)
Takeda Pharmaceutical Company Limited(Japan)
Boehringer Ingelheim(Germany)
Sun Pharmaceutical Industries Ltd.(India)
결론과 제안
KSA
영문 목차
영문목차
Global Vaginitis Therapeutics Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 3.99 billion in 2024 to USD 7.27 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).
The global vaginitis therapeutics market is witnessing a surge in demand for effective treatments, driven by the increasing prevalence of vaginal infections. Key market trends reveal a shift toward personalized and minimally invasive solutions, with growing interest in antimicrobial agents and probiotics. Technological advancements are catalyzing the creation of innovative formulations and diagnostic tools. Major companies are actively investing in research and forming partnerships to broaden their product offerings. While North America and Europe currently dominate the market due to robust healthcare infrastructure and heightened awareness, emerging economies in the Asia-Pacific region present significant growth opportunities, spurred by enhancing healthcare access and rising awareness of vaginal health.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vaginitis Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Vaginitis Therapeutics Market Segments Analysis
Global Vaginitis Therapeutics Market is segmented by Disease, Product, Distribution Channel and region. Based on Disease, the market is segmented into Anti-fungal, Anti-bacterial and Hormone. Based on Product, the market is segmented into Over-the-counter (OTC) and Prescription. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Vaginitis Therapeutics Market
The global market for vaginitis therapeutics is primarily driven by the widespread occurrence of vaginitis, which encompasses several types of vaginal infections and inflammatory conditions affecting women globally. This high prevalence directly influences the demand for effective treatments. Contributing factors, such as inadequate hygiene, the use of specific contraceptive methods, antibiotic therapies, and fluctuations in hormonal levels, further exacerbate the incidence of vaginitis. As awareness of women's health issues grows and the need for effective remedies increases, the market for vaginitis therapeutics is expected to expand significantly in response to these compelling drivers.
Restraints in the Global Vaginitis Therapeutics Market
One of the significant restraints affecting the Global Vaginitis Therapeutics market is the widespread use of antibiotics for treating bacterial vaginosis, a common vaginitis condition. The over-prescription and inappropriate use of these antibiotics have contributed to the development of antibiotic-resistant bacterial strains. This resistance not only diminishes the effectiveness of standard antibiotic treatments but also complicates the overall management of bacterial vaginosis, potentially leading to increased healthcare costs and challenges in developing effective therapeutic strategies. As healthcare providers navigate this evolving landscape, the efficacy of existing treatments is being scrutinized, creating hurdles for market growth.
Market Trends of the Global Vaginitis Therapeutics Market
The Global Vaginitis Therapeutics market is witnessing a notable trend characterized by rising awareness and education surrounding vaginal health and infections. As more women become informed about their reproductive health issues, there is an increased demand for precise diagnosis, treatment, and prevention strategies for vaginitis. This heightened awareness is prompting a greater number of women to seek medical assistance promptly, which is expected to boost the demand for effective therapeutic solutions. Consequently, pharmaceutical companies are likely to focus on developing innovative treatments, further propelling market growth and advancements in the sector to cater to this growing consumer awareness.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Analysis
Global Vaginitis Therapeutics Market Size by Disease & CAGR (2025-2032)
Market Overview
Anti-fungal
Anti-bacterial
Hormone
Global Vaginitis Therapeutics Market Size by Product & CAGR (2025-2032)
Market Overview
Over-the-counter (OTC)
Prescription
Global Vaginitis Therapeutics Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Hospital Pharmacies
Retail Pharmacies
Others
Global Vaginitis Therapeutics Market Size & CAGR (2025-2032)
North America (Disease, Product, Distribution Channel)
US
Canada
Europe (Disease, Product, Distribution Channel)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Disease, Product, Distribution Channel)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Disease, Product, Distribution Channel)
Brazil
Rest of Latin America
Middle East & Africa (Disease, Product, Distribution Channel)
